Skip to search boxSkip to navigationSkip to main content

Isolated Bovine Spinal Motoneurons Have Specific Ganglioside Antigens Recognized by Sera from Patients with Motor Neuron Disease and Motor Neuropathy

  • Hiide Yoshino
    ,
  • Nobuyuki Miyatani
    ,
  • Megumi Saito
    ,
  • Toshio Ariga
    ,
  • Alessandra Lugaresi
    ,
  • Norman Latov
*Corresponding author for this work
  • Virginia Commonwealth University
    ,
  • Columbia University
    ,
  • Institute of Science Tokyo
Scholary Output:
Contribution to journal
Article
Peer-review

Sustainable Development Goals

  • SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well

Abstract

Abstract: The gangliosides GM1 and GD1b have recently been reported to be potential target antigens in human motor neuron disease (MND) or motor neuropathy. The mechanism for selective motoneuron and motor nerve impairment by the antibodies directed against these gangliosides, however, is not fully understood. We recently investigated the ganglioside composition of isolated bovine spinal motoneurons and found that the ganglioside pattern of the isolated motoneurons was extremely complex. GM1, GD1a, GD1b, and GT1b, which are major ganglioside components of CNS tissues, were only minor species in motoneurons. Among the various ganglioside species in motoneurons, several were immunoreactive to sera from patients with MND and motor neuropathy. One of these gangliosides was purified from bovine spinal cord and characterized as N‐glycolylneuraminic acid‐containing GM1 [GM1(NeuGc)] by compositional analysis, fast atom bombardment mass spectra, and the use of specific antibodies. Among seven sera with anti‐GM1 antibody activities, five sera reacted with GM1(NeuGc) and two did not. Two other gangliosides, which were recognized by another patient's serum, appeared to be specific for motoneurons. We conclude that motoneurons contained, in addition to the known ganglioside antigens GM1 and GDlb, other specific ganglioside antigens that could be recognized by sera from patients with MND and motor neuropathy.

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 1684-1691 (8 pages)

Journal (Volume, Issue Number)

Journal of Neurochemistry (Volume 59, Issue 5)

Publication milestones

  • Published - 11/1992

Publication status

Published - 11/1992

ISSN

0022-3042

Publication IDs

  • Scopus: 0026778734
  • PubMed: 1383424

Publication metrics

Metrics

Fractional count
1
Fractional count
0.11
Fractional count
8
Fractional count
0.89
Fractional count
1
Fractional count
1
Scopus
citations

PlumX, opens in new tab

Citation count
20
Captures
8

Funding Details

FunderFunding number
NINDS
R01NS011853